Bactiguard Holding

Bactiguard Holding AB is a global MedTech company based in Stockholm, Sweden, specializing in the development of biocompatible technology to prevent infections associated with medical devices. The company's proprietary technology involves an ultra-thin noble metal coating that reduces bacterial adhesion and biofilm formation. Bactiguard operates primarily through license partnerships with leading MedTech companies, allowing them to apply its infection prevention technology to their medical devices. The company also offers a portfolio of wound management products, contributing to its mission of reducing patient suffering and combating antimicrobial resistance.

153

1.67

1.13

— Bactiguard Holding
%
Infection Prevention Technology60% Technology to prevent infections on medical devices.
License Partnerships30% Collaborations with MedTech companies to apply technology.
Wound Management Products10% Products aimed at wound care and management.

Bactiguard's customers primarily include global MedTech companies that integrate its infection prevention technology...

  • MedTech Companiesprimary

    Purchase technology for integration into medical devices.

  • Healthcare Providerssecondary

    Use wound management products to improve patient care.

  • Institutional Buyersemerging

    Seek solutions to reduce healthcare costs and improve outcomes.

Bactiguard is headquartered in Stockholm, Sweden, and operates globally through its partnerships with leading MedTech...

  • •Headquartered in Stockholm, Sweden
  • •Global operations through MedTech partnerships
  • •Presence in Europe, North America, and Asia
  • •Strategic focus on diverse market penetration

Bactiguard's strategic priorities include expanding its license partnerships and increasing the application areas for...

01
Expand License Partnershipsmedium-term

To increase market reach and application areas.

02
Achieve SEK 200 million EBITDAlong-term

To ensure financial growth and stability.

03
Enhance Wound Management Portfolioshort-term

To capture growth in wound care market.

Bactiguard faces several risks, including dependency on key partnerships and regulatory challenges in different markets...

high

Dependency on Partnerships

Revenue heavily reliant on MedTech collaborations.

Materiality
high
medium

Regulatory Challenges

Delays in approvals can impact market entry.

Materiality
medium
medium

Currency Fluctuations

Global operations expose to exchange rate risks.

Materiality
medium
Revenue Recognition
Significant on financial results
Currency Fluctuations
Material on financial statements
Provisions for Inventory
Critical for accurate assessment

Essity A

ESSITY-B.ST · Consumer Staples

Getinge

GETI-B.ST · Health Care

Matinas BioPharma Holdings, Inc.

MTNB · Pharmaceutical Preparations

Citius Pharmaceuticals, Inc.

CTXR · Pharmaceutical Preparations

Stockwik Förvaltning

STWK.ST · Financials

BiomX Inc.

PHGE · Biological Products, (No Diagnostic Substances)

: 11/08/2026